loading...| Preferred Name | Sulfasalazine | |
| Synonyms |
Sulfasalazine FNA Sulfasalazin Heyl Colo-Pleon ratio-Sulfasalazine Azulfidine EN Benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)- ratio Sulfasalazine Sulfasalazin-Heyl Sulphasalazine Azulfidine Colo Pleon Sulfasalazin medac Pyralin EN Salazopyrin Salazosulfapyridine Ucine Pleon Asulfidine Ulcol Salicylazosulfapyridine Azulfadine |
|
| Definitions |
A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D012460 |
|
| altLabel |
Sulfasalazine FNA Sulfasalazin Heyl Colo-Pleon ratio-Sulfasalazine Azulfidine EN Benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)- ratio Sulfasalazine Sulfasalazin-Heyl Sulphasalazine Azulfidine Colo Pleon Sulfasalazin medac Pyralin EN Salazopyrin Salazosulfapyridine Ucine Pleon Asulfidine Ulcol Salicylazosulfapyridine Azulfadine |
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C4505433 C0036078 C1564232 C0731586 C4082693 C1564233 C0699547 C1564234 C1564231 C1564235 C1564230 |
|
| DC |
1 |
|
| definition |
A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) |
|
| DX |
19950101 |
|
| HN |
1995 (1963) |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
3XC8GUZ6CB 0 |
|
| isa |
http://purl.bioontology.org/ontology/MESH/D000890 http://purl.bioontology.org/ontology/MESH/D000894 |
|
| LT |
TRD |
|
| Machine permutation |
1995; see SALICYLAZOSULFAPYRIDINE 1963-1994; for SULFASALAZINE see SALICYLAZOSULFAPYRIDINE 1975-1994 |
|
| Mapped from |
http://purl.bioontology.org/ontology/MESH/C009943 http://purl.bioontology.org/ontology/MESH/C024308 http://purl.bioontology.org/ontology/MESH/C016095 http://purl.bioontology.org/ontology/MESH/C028423 http://purl.bioontology.org/ontology/MESH/C012544 http://purl.bioontology.org/ontology/MESH/C024059 |
|
| MDA |
19990101 |
|
| MMR |
20180301 |
|
| MN |
D02.065.884.730 D02.886.590.700.730 |
|
| notation |
D012460 |
|
| PA |
D000894 D000890 D018501 D005765 |
|
| prefLabel |
Sulfasalazine |
|
| RR |
599-79-1 (Sulfasalazine) |
|
| TERMUI |
T748040 T619004 T037016 T618973 T037018 T037015 T618998 T037021 T618996 T037017 T618972 T618994 T618971 T619000 T037020 T037014 T037019 T619002 |
|
| TH |
US UK NL NLM (1995) CA FDA SRS (2014) UNK (19XX) INN (19XX) NLM (2010) DE AU USAN (1975) USP (19XX) BAN (19XX) IE |
|
| tui |
T109 T121 |
|
| subClassOf |